Performance and Safety of MUCOGYNE® Ovule as a Moisturizer

Exclusion Criteria

• •Women with the following conditions:
• •General criteria:
• •Pregnant women (patient of childbearing potential must not be pregnant and must agree to avoid pregnancy during the study by using an effective birth control method from at least one month before D0 (V1) and throughout the duration of the study)
• •Patient participating at the same time in another interventional trial within the four previous weeks and during the study period, being in an exclusion period for a previous study
• •Patient deprived of freedom by administrative or legal decision or under guardianship
• •Patient in a social or sanitary establishment
• •Patient suspected to be non-compliant according to the investigator's judgment
• •Patient in an emergency situation
• •Criteria related to patient's status:
• •Patient with known hypersensitivity to one of MUCOGYNE® Ovule components
• •Patient with a known vaginal pathology (clinical diagnosis only) other than vaginal dryness/atrophy
• •Criteria related to previous or ongoing treatments:
• •Patient with a condition or receiving a medication which, in the investigator's judgment, put the patient at undue risk
• •Patient suffering from systemic diseases and/or using concurrent therapy that may interfere with the evaluation of the study results
• •Patient undergoing a topical treatment on the test area or a systemic treatment such as:
• •* corticosteroids during the 2 previous weeks and during the study
• •* retinoids and/or immunosuppressors during the 1.5 previous months and during the study
• •* Patient having started or changed her oral contraceptive or any other hormonal treatment during the three previous months